ZNF384 Gene

HGNC Family	Zinc fingers, Trinucleotide repeat containing (TNRC)
Name	zinc finger protein 384
Description	This gene encodes a C2H2-type zinc finger protein, which may function as a transcription factor. This gene also contains long CAG trinucleotide repeats that encode consecutive glutamine residues. The protein appears to bind and regulate the promoters of the extracellular matrix genes MMP1, MMP3, MMP7 and COL1A1. Studies in mouse suggest that nuclear matrix transcription factors (NP/NMP4) may be part of a general mechanical pathway that couples cell construction and function during extracellular matrix remodeling. Alternative splicing results in multiple transcript variants. Recurrent rearrangements of this gene with the Ewing's sarcoma gene, EWSR1 on chromosome 22, or with the TAF15 gene on chromosome 17, or with the TCF3 (E2A) gene on chromosome 19, have been observed in acute leukemia. A related pseudogene has been identified on chromosome 7. [provided by RefSeq, Apr 2011]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nZNF384 functions predominantly as a transcription factor whose deregulation through fusion events defines a distinct subgroup of acute leukemia. In B‐cell precursor acute lymphoblastic leukemia (ALL) and mixed phenotype leukemia, rearrangements that fuse the entire ZNF384 coding region to various partner genes (including TAF15, TCF3, EP300, CREBBP, among others) are associated with a characteristic immunophenotype (often low CD10 with aberrant CD13/CD33 expression) and unique gene expression signatures. These fusion proteins enhance transcriptional activity, reprogram enhancer landscapes, and promote aberrant expression of stem cell– and cytokine receptor–related genes such as FLT3 and IL3RA, thereby influencing leukemic cell proliferation, differentiation, and drug sensitivity. Moreover, the clinical behavior of ZNF384‐rearranged leukemias appears to depend on the fusion partner, with certain fusions correlating with differences in relapse risk and measurable residual disease status."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond hematologic malignancies, ZNF384 also plays a role in solid tumors. In colorectal cancer, elevated expression of ZNF384 contributes to tumor metastasis by upregulating molecules such as MMP2, with its expression driven in part by hypoxia‐inducible factor 1α. Similarly, in glioma, ZNF384 functions as a transcriptional activator in a regulatory axis involving LINC00265, miR‐let‑7d‑5p, IFI30, and IGF2BP2, thereby promoting stemness and epithelial-to-mesenchymal transition. These findings suggest that ZNF384 not only drives leukemogenesis through fusion‐mediated transcriptional dysregulation but also contributes to tumor progression in non‐hematologic cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kaja Beate Nyquist, Jim Thorsen, Bernward Zeller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cancergen.2011.01.003"}], "href": "https://doi.org/10.1016/j.cancergen.2011.01.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21504714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21504714"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mary Shago, Oussama Abla, Johann Hitzler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Blood Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pbc.26116"}], "href": "https://doi.org/10.1002/pbc.26116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27392123"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27392123"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shinsuke Hirabayashi, Kentaro Ohki, Kazuhiko Nakabayashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3324/haematol.2016.151035"}], "href": "https://doi.org/10.3324/haematol.2016.151035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27634205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27634205"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Maoxiang Qian, Hui Zhang, Shirley Kow-Yin Kham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gr.209163.116"}], "href": "https://doi.org/10.1101/gr.209163.116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27903646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27903646"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Akinori Yaguchi, Takeshi Ishibashi, Kazuki Terada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Hematol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12185-017-2220-6"}], "href": "https://doi.org/10.1007/s12185-017-2220-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28378055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28378055"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Barbara J McClure, Susan L Heatley, Chung H Kok, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-018-0022-0"}], "href": "https://doi.org/10.1038/s41416-018-0022-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29531323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29531323"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nancy Beryl Janet, Uday Kulkarni, Arunachalam Kumar Arun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Lab Hematol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/ijlh.13580"}], "href": "https://doi.org/10.1111/ijlh.13580"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33988307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33988307"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Marketa Zaliova, Lucie Winkowska, Jan Stuchly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel class of ZNF384 aberrations in acute leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Adv (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/bloodadvances.2021005318"}], "href": "https://doi.org/10.1182/bloodadvances.2021005318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34529760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34529760"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kirsten M Dickerson, Chunxu Qu, Qingsong Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cancer Discov (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2643-3230.BCD-21-0163"}], "href": "https://doi.org/10.1158/2643-3230.BCD-21-0163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35247902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35247902"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Tugce Sudutan, Yucel Erbilgin, Ozden Hatirnaz Ng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Zinc finger protein 384 ("}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "ZNF384"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": ") impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Lymphoma (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/10428194.2022.2095630"}], "href": "https://doi.org/10.1080/10428194.2022.2095630"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35921545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35921545"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shinsuke Hirabayashi, Atsushi Manabe, Kentaro Ohki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Rinsho Ketsueki (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.11406/rinketsu.64.633"}], "href": "https://doi.org/10.11406/rinketsu.64.633"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37544723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37544723"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zong-Yan Shi, Xu Wang, Wen-Min Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hematol Oncol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hon.3251"}], "href": "https://doi.org/10.1002/hon.3251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38287528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38287528"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhijie Hou, Yifei Ren, Xuehong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Commun Signal (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12964-024-01596-9"}], "href": "https://doi.org/10.1186/s12964-024-01596-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38566191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38566191"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Chiharu Yamada, Kentaro Okada, Koya Odaira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.7471"}], "href": "https://doi.org/10.1002/cam4.7471"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39015025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39015025"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Zaihua Yan, Yu Zhou, Yang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2022.8260"}], "href": "https://doi.org/10.3892/or.2022.8260"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35029289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35029289"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jian Yang, Shenghe Yang, Jinlian Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "ACS Chem Neurosci (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acschemneuro.3c00562"}], "href": "https://doi.org/10.1021/acschemneuro.3c00562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38141017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38141017"}]}]}]}
Synonyms	CAGH1, CIZ, ERDA2, TNRC1, NMP4, CAGH1A
Proteins	ZN384_HUMAN
NCBI Gene ID	171017
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

ZNF384 has 5,377 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 111 datasets.

Click the + buttons to view associations for ZNF384 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

ZNF384 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of ZNF384 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of ZNF384 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of ZNF384 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of ZNF384 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of ZNF384 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of ZNF384 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of ZNF384 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of ZNF384 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of ZNF384 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of ZNF384 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of ZNF384 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of ZNF384 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CCLE Cell Line Gene Mutation Profiles	cell lines with ZNF384 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
	CCLE Cell Line Proteomics	Cell lines associated with ZNF384 protein from the CCLE Cell Line Proteomics dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZNF384 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of ZNF384 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of ZNF384 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CM4AI U2OS Cell Map Protein Localization Assemblies	assemblies containing ZNF384 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of ZNF384 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing ZNF384 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores	cellular components containing ZNF384 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores 2025	cellular components containing ZNF384 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with ZNF384 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with ZNF384 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of ZNF384 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with ZNF384 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with ZNF384 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	DeepCoverMOA Drug Mechanisms of Action	small molecule perturbations with high or low expression of ZNF384 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by ZNF384 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores 2025	diseases associated with ZNF384 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with ZNF384 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with ZNF384 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with ZNF384 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with ZNF384 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at ZNF384 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZNF384 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of ZNF384 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing ZNF384 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GDSC Cell Line Gene Expression Profiles	cell lines with high or low expression of ZNF384 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
	GeneRIF Biological Term Annotations	biological terms co-occuring with ZNF384 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.